1) salmeterol
沙美特罗
1.
Determination of liposome/water partition coefficients of salmeterol and budesonide and study on their influencing factors;
沙美特罗和布地奈德的脂质体/水分配系数测定及影响因素考察
2.
Efficacy Evaluation of Roxithromycin and Salmeterol Combinated Treatment for Asthmatic Children;
罗红霉素联合沙美特罗治疗支气管哮喘
3.
Evaluation of the efficacy of the salmeterol/fluticasone propionate turbuhaler compared with fluticasone metered daerosal in the treatment of moderate asthma;
沙美特罗/丙酸氟替卡松干粉剂与丙酸氟替卡松气雾剂治疗中度支气管哮喘的疗效比较
2) R-salmeterol
R-沙美特罗
1.
The main asymmetric synthetic methods for optically active 2-amino-l-phenylethanol derivatives are summarized according to reaction type such as asymmetric hydrogenation, CBS-oxazaborolidine reduction and Henry reaction, especially for the synthetic methodology of R-salbutamol, R-salmeterol and D-sotalol.
重点介绍了不对称氢化、CBS还原、不对称Henry反应等新方法在2-氨基-1-苯基乙醇类药物如R-沙丁胺醇、R-沙美特罗和D-索他洛尔等合成中的应用。
3) Salmeterol/fluticasone propionate
沙美特罗替卡松
1.
Lung function and safety of children with moderate-severe asthma treated by salmeterol/fluticasone propionate;
沙美特罗替卡松治疗儿童中重度哮喘的肺功能及安全性观察
4) Salmeterol/Fluticasone
沙美特罗替卡松
1.
The Improvement of Salmeterol/Fluticasone on Inspiratory Capacity in Patients with Stable Chronic Obstructive Pulmonary Disease;
沙美特罗替卡松对稳定期COPD患者深吸气量的改善作用
2.
Salmeterol/Fluticasone Powder Inhalation for Patients with Cough-Variant Asthma: Clinical Observation on 43 Cases;
沙美特罗替卡松粉吸入剂治疗咳嗽变异型哮喘43例临床观察
5) The Synthesis of Salmeterol
沙美特罗的合成
6) salmeterol xinafoate
羟萘甲酸沙美特罗
1.
Determination of content of salmeterol xinafoate in aerosol by HPLC;
HPLC法测定羟萘甲酸沙美特罗气雾剂含量
2.
A simple capillary gas chromatography method was established for the determination of residual ethoxyethane, ethanol, isopropanol, ethyl acetate, tetrahydrofuran, chloroform and toluene in salmeterol xinafoate.
采用毛细管气相色谱法 ,以外标法测定羟萘甲酸沙美特罗中乙醚、乙醇、异丙醇、乙酸乙酯、四氢呋喃、氯仿和甲苯的含量 ,用串联的 HP- 1(0 。
补充资料:沙美特罗
分子式:C25H37NO3
分子量:暂无
CAS号:89365-50-4
性质:暂无
制备方法:暂无
用途:支气管扩张药。
分子量:暂无
CAS号:89365-50-4
性质:暂无
制备方法:暂无
用途:支气管扩张药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条